Universal adapter reagents for DNA synthesis

By using platinum-coated electrodes and cleavable universal adapters in DNA synthesis, the problems of long oligomer release time and quality impact in existing technologies are solved, achieving efficient and rapid DNA synthesis and purification.

CN117222647BActive Publication Date: 2026-11-17GENSCRIPT USA INC +1
View PDF 20 Cites 0 Cited by

Patent Information

Application Number
CN202280030016.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-03-22
Filing Date
2022-03-22
Publication Date
2026-11-17
Estimated Expiration
2042-03-22

AI Technical Summary

Technical Problem

In existing DNA synthesis methods, electrode arrays using porous coatings with absorption have problems such as long oligomer release time, significant quality impact, and degradation issues. In addition, the cutting time of universal adapters is long, which affects the efficiency and quality of DNA synthesis.

Method used

Using an improved solid support medium approach, platinum-coated electrodes and universal adapters are employed. The electrodes are coated with substituted or unsubstituted aliphatic, aromatic, or other groups and functionalized with cleavable universal adapters to achieve rapid DNA release.

Benefits of technology

It improves the efficiency and quality of oligonucleotide synthesis, simplifies the oligonucleotide cleavage process, reduces the impact of 3'-modification, and improves the yield and purity of DNA synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117222647B_ABST
    Figure CN117222647B_ABST
Patent Text Reader

Abstract

This article provides methods and compositions for oligonucleotide synthesis using a universal linker phosphorus amide. Methods and reagents for electrochemical DNA synthesis are described, wherein DNA synthesis is performed using a controlled-pore glass (CPG) solid support on a platinum-coated electrode. The universal linker can be used as a spacer in single-column PCR primer synthesis to produce two strands with free 3'-hydroxyl ends after cleavage. These methods and compositions utilize a solid support system for oligonucleotide synthesis, wherein the support has a platinum electrode and a universal linker, optionally wherein the platinum electrode is coated with an amine. The use of the universal linker phosphorus amide is further described in these methods and compositions, and the platinum electrode is coated with a monosaccharide or disaccharide.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references to related applications

[0002] This application is an international application pursuant to the Patent Cooperation Treaty, claiming priority to U.S. Provisional Patent Application No. 63 / 164,363, filed March 22, 2021, the entire contents of which are incorporated herein by reference. Technical Field

[0003] The present invention provides an electrode array for electrochemical synthesis of oligomers via a combination of a universal connector technique and a solid support device having coated electrodes (e.g., platinum electrodes). Background Technology

[0004] The rapid development of the DNA microarray field has spurred numerous methods for the synthetic preparation of DNA. These methods include spot-presynthesized oligonucleotides, photolithography using masked or maskless techniques, in-situ synthesis via printing reagents, and in-situ parallel synthesis using electrochemical deblocking of electrode microarrays with protective groups. A review of oligonucleotide microarray synthesis is provided, for example, by Gao et al., Biopolymers 2004, 73:579. The synthesis of peptide arrays using photomasking techniques was reported in 1991. This method was expanded in 2000 to include addressable masking techniques using photoacids and / or combinations with photosensitizers for deblocking. A review of peptide microarray synthesis using photostable deblocking is provided by Pellois et al., J.Comb.Chem. 2000, 2:355 and Fodor et al., Science, 1991, 251:767. Spot-presynthesized peptides or isolated proteins have been used to generate peptide arrays. A review of protein or peptide arrays is provided by: Cahill and Nordhoff, Adv. Biochem. Engin / Biotechnol. 2003, 83:177. Universal supports can be used in DNA synthesis due to the labor-intensive nature of using four different solid supports (or more) to prepare 3'-unmodified oligonucleotides.

[0005] Two different types of universal connectors (UL) are commercially available. Both types of connectors have vicinal diol structures that are individually protected as an acid-sensitive 4,4'-dimethoxytriphenylmethyl (DMT) group (for oligomer extension) and a base-sensitive acyl group (for oligomer release during deprotection). The first type of connector (Universal Support III, USIII) is released by treatment with anhydrous ammonia (Azhayev, 2001, Nucleosides Nucleotides Nucleic Acids, 20(4-7):539-50; Yagodkin, 2011, Nucleosides Nucleotides Nucleic Acids, 30(7-8):475-89), and is described, for example, in US Patent No. 6,770,754. The second type of UL (UNYLINKER) TM or UNYSUPPORT TM The release is achieved using ammonia (Guzaev, 2003) or anhydrous methylamine gas (US Patent 7,202,264). Electrochemical parallel DNA synthesis on CMOS (complementary metal-oxide-semiconductor) electrode arrays has been described (Maurer et al., 2006, PLoS One. December 20, 2006; 1(1):e34; US Patent No. 10,525,436). In this application, an absorbent porous reaction layer is coated onto the surface of a CMOS chip on each platinum electrode prior to DNA synthesis. DNA synthesis begins with hydroxyl groups on the porous layer. After DNA synthesis, the oligomers are either left on the chip or cleaved from the chip surface. One problem with absorbent porous coatings is the long cleavage time for releasing oligomers. Long cleavage times slow down DNA synthesis and may affect DNA quality. The released oligomers may still have absorbent coated molecules attached to the 3'-end. 3'-modification of the DNA strand is a problem for some applications (such as PCR primers) because 3'-modification blocks polymerase elongation. Another problem with the coating absorbed on the electrode is degradation during DNA synthesis or when used in multiple hybridization assays.

[0006] This invention addresses these challenges by providing a method for synthesizing oligonucleotides using an improved solid support medium with universal linkers. Summary of the Invention

[0007] This article provides methods and compositions for oligonucleotide synthesis using universal adapters coated on electrodes or used as spacers in single-column PCR primer synthesis.

[0008] In one embodiment, these methods and compositions may comprise a solid support system for oligonucleotide synthesis, wherein the support comprises platinum electrodes and universal adapters. In several embodiments, the platinum electrodes are first coated with substituted or unsubstituted aliphatic groups, substituted or unsubstituted aliphatic ethers, substituted or unsubstituted heteroalkyl groups, substituted or unsubstituted aromatic groups (e.g., polybenzyl alcohol groups), substituted or unsubstituted heteroaryl groups, or substituted or unsubstituted heterocyclic groups to allow DNA synthesis to begin. The alcohol-coated electrodes are further functionalized with cleavable universal adapters to allow DNA release after synthesis and deprotection. In some embodiments of this disclosure, the solid support may comprise platinum electrodes and dielectrics (insulators) separating the individual platinum electrodes on a coated surface. The dielectric may be at least one selected from the group consisting of silicon oxynitride, silicon nitride, silicon dioxide, and tetraethyl orthosilicate (TEOS).

[0009] In the embodiments, the method for synthesizing oligonucleotides may include using the compositions described herein.

[0010] In one aspect, this disclosure may relate to a solid support system for synthesizing oligonucleotides, wherein the support may include a planar surface and a universal adapter, wherein the universal adapter may be coupled (attached or connected) to the planar surface.

[0011] On the other hand, the flat surface can be coated with amine before attaching the universal connector.

[0012] On the other hand, carboxylic acids can be used to coat flat surfaces.

[0013] On the other hand, the planar surface can be made of silicon, titanium, or platinum.

[0014] On the other hand, the solid support system may contain formula (I), (III), or (IV), optionally wherein a universal connector can be coupled to the planar surface by reacting it with a compound having formula (II), (V), (VI), (VII), (VIII), (IX), (X), or a combination thereof.

[0015] (a) Formula (I):

[0016]

[0017] Wherein, when A is a connecting portion attached to a coated platinum electrode containing substituted or unsubstituted aliphatic groups, substituted or unsubstituted aliphatic ethers, substituted or unsubstituted heteroalkyl groups, substituted or unsubstituted aromatic groups, or substituted or unsubstituted heterocyclic groups, one of W or Q is a blocking group that can be cleaved under alkaline or neutral conditions, while the other of W or Q is H, or a blocking group that can be cleaved under acidic conditions; or

[0018] Wherein, when A is H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aliphatic ether, a substituted or unsubstituted heteroalkyl group, a substituted or unsubstituted aromatic group, or a substituted or unsubstituted heterocyclic group, one of Q or W is a connector portion attached to the coated platinum electrode that is cleavable under alkaline or neutral conditions, while the other of W or Q is H, or a blocking group that is cleavable under acidic conditions.

[0019] (b) Equation (II):

[0020]

[0021] (c) Equation (III):

[0022]

[0023] in

[0024] R is an alkyl, aryl, heteroalkyl, or heteroaryl group attached to a platinum electrode or other base material;

[0025] A is NH, O, S, alkyl, or aryl;

[0026] X is an acyl, aryl, or silyl group; and

[0027] Y is a dimethoxytriphenylmethyl group or a protecting group that can be removed under acidic or neutral conditions;

[0028] (d) Equation (IV):

[0029]

[0030] R1 is an alkyl, aryl, heteroalkyl, or heteroaryl group attached to a platinum electrode or other base material.

[0031] (e) Equation (V):

[0032]

[0033] (f) Equation (VI):

[0034]

[0035] in

[0036] A is

[0037] X is an acyl, aryl, or silyl group; and

[0038] Y is a dimethoxytriphenylmethyl group or a protecting group that can be removed under acidic or neutral conditions;

[0039] (g) Equation (VII):

[0040]

[0041] (h) Equation (VIII):

[0042]

[0043] in

[0044] A is

[0045] X is an acyl, aryl, or silyl group; and

[0046] Y is a dimethoxytriphenylmethyl group or a protecting group that can be removed under acidic or neutral conditions;

[0047] (i) Equation (IX):

[0048]

[0049] (j) Equation (X):

[0050]

[0051] On the other hand, the compound may have formulas (II), (IV), (V), (VII), (IX), (X), or combinations thereof.

[0052] On the other hand, compounds may have formulas (VII), (IX) or (X).

[0053] On the other hand, monosaccharides or disaccharides can be used to coat planar surfaces.

[0054] On the other hand, monosaccharides can be selected from the group consisting of: allose, arabinose, arabinose, deoxyribose, erythrose, fructose, galactose, glucose, gulose, idose, lysolose, mannose, allulose, L-rhamnose, ribose, ribulose, sedoheptulose, D-sorbitol, sorbose, sylulose, tagatose, taloose, threose, xylulose, and xylose, and disaccharides can be selected from the group consisting of: sucrose, amylose, cellobiose, lactose, maltose, melibiose, isomaltulose, and trehalose.

[0055] In one aspect, this disclosure may relate to a method for synthesizing an oligonucleotide, the method comprising: (a) providing an electrode device having a planar surface; (b) coupling said surface to a universal connector; and (c) synthesizing the oligonucleotide.

[0056] In another aspect, the method may further include the step of electrochemically depositing carboxylic acid to reduce the amount of carboxylic acid on the planar surface.

[0057] On the other hand, the method may further include depositing an amine coating onto the activated carboxylic acid.

[0058] On the other hand, the planar surface may contain silicon, titanium or platinum.

[0059] On the other hand, the solid support system may contain formula (I), (III) or (IV), optionally wherein a universal connector can be coupled to the planar surface by reacting the planar surface with a compound having formula (II), (V), (VI), (VII), (VIII), (IX), (X) or a combination thereof.

[0060] In one aspect, this disclosure may relate to a method for synthesizing oligonucleotide primer pairs, the method comprising providing a solid support comprising a first universal adapter fixed to the surface of the solid support; performing a first phosphoramidite DNA synthesis to generate a first oligonucleotide primer, wherein the 3' end of the first oligonucleotide primer is attached to the first universal adapter; coupling a second universal adapter to the 5' end of the first oligonucleotide primer; performing a second phosphoramidite DNA synthesis to generate a second oligonucleotide primer, wherein the 3' end of the second oligonucleotide primer is attached to the second universal adapter; and contacting the solid support with a releasing agent to release the first oligonucleotide primer and the second oligonucleotide primer from the solid support, wherein each of the released first oligonucleotide primer and the released second oligonucleotide primer contains a 3'-hydroxyl group.

[0061] On the other hand, the first universal joint can be fixed to the solid support by reacting the solid support with a first compound having formula (VI), (VII), (VIII), (IX), (X) or a combination thereof.

[0062] On the other hand, the first compound has formula (VII), (IX) or (X).

[0063] On the other hand, a second universal adapter can be attached to the first oligonucleotide primer by reacting the first oligonucleotide primer with a second compound having formula (VII), (IX) or (X).

[0064] On the other hand, the releasing agent may include 4M methylamine / MeOH or TEA:3HF.

[0065] In another aspect, the method may further include removing the protecting groups from the released first oligonucleotide primer and the released second oligonucleotide primer with AMA (1:1, 37% ammonium hydroxide: 40% methylamine).

[0066] On the other hand, the lengths of the first and second oligonucleotide primers released can be approximately the same.

[0067] On the other hand, the concentration ratio of the released first oligonucleotide primer to the released second oligonucleotide primer can be approximately 1:1.

[0068] On the other hand, this method can be performed in a single column.

[0069] On the other hand, compounds can have the formula (X).

[0070] In one respect, this disclosure may relate to a compound having formula (XI),

[0071]

[0072] in

[0073] A is

[0074] X is an acyl, aromatic, or silyl group, and

[0075] Y is a dimethoxytriphenylmethyl group, or a protecting group that can be removed under acidic or neutral conditions.

[0076] On the other hand, n can be 5.

[0077] On the other hand, X can be silyl group.

[0078] On the other hand, the silyl group can be trimethylsilyl, triethylsilyl, tert-butyldiphenylsilyl, tert-butyldimethylsilyl, or triisopropylsilyl.

[0079] On the other hand, silyl can be tert-butyldimethylsilyl.

[0080] On the other hand, Y can be a dimethoxytriphenylmethyl group.

[0081] On the other hand, the compound may include (R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-2,2,3,3-tetramethyl-8-oxo-4-oxa-7,9-diaza-3-silazopentane-15-yl-cyanoethyldiisopropylphosphonamide.

[0082] In one aspect, this disclosure may relate to a method for synthesizing an oligonucleotide, the method comprising: (a) providing a solid support system of the present disclosure; (b) coupling the surface to a universal adapter; and (c) synthesizing the oligonucleotide.

[0083] On the other hand, titanium can include titanium nitride.

[0084] On the other hand, the planar surface may include a plurality of platinum electrodes separated by at least one dielectric.

[0085] On the other hand, the at least one dielectric can be selected from the group consisting of silicon oxynitride, silicon nitride, silicon dioxide and tetraethyl orthosilicate (TEOS). Attached Figure Description

[0086] Figure 1 A comparison of the universal support structures is shown. In each case, DNA synthesis begins with a dimethoxytriphenylmethyl (DMT) group in the adapter structure. Base treatment releases an oligonucleotide with an unmodified 3'-hydroxy terminus.

[0087] Figure 2 The release and immobilization of synthesized oligonucleotides were demonstrated. Treatment with anhydrous ammonia in methanol rapidly cleaved the chloroacetyl group, while treatment with fluoride ions cleaved the silyl protecting group. The resulting dephosphorylation released the oligomers. Treatment with tert-butylamine in ACN rapidly cleaved the cyanoethyl group and immobilized the oligomers to the surface.

[0088] Figure 3 UNYLINKER was displayed. TM The reaction of an acid with an amine-coated solid support. UNYLINKER TM The structure is "pre-organized" using ortho-hydroxy groups on the same side of the rigid ring system. The dephosphorylation and release of the 3'-hydroxy oligonucleotide are very rapid when the base-sensitive succinate linker is hydrolyzed.

[0089] Figure 4 A method for synthesizing linker amine 3 is shown. The novel (R) isomer is readily prepared and used as a synthon for each universal linker phosphorous amide (ULP).

[0090] Figure 5 A method for synthesizing ULP 1 is shown. First, 4-nitrophenyl 6-(tert-butyldimethylsilyloxy)hexylcarbamate is prepared and coupled to a linker amine 3 to generate a urea bond. After dichloroacetylation, the TBDMS group is selectively removed with tetrabutylammonium fluoride (TBAF), followed by phosphorylation to obtain phosphoramide.

[0091] Figure 6 A method for synthesizing ULP 2 is shown. The structure is similar to ULP 1, but the urethane bond is generated by reacting TBDPS-protected 1,6-hexanediol with p-nitrophenyl chloroformate and coupling it to a connector amine 3. After dichloroacetylation, the TBDPS group is selectively removed with TBAF, followed by phosphorylation to obtain a phosphoramide.

[0092] Figure 7 A method for synthesizing ULP 3 is shown. The structure is similar to ULP 1, but a silyl protecting group (TBDMS) is used instead of a dichloroacetyl protecting group.

[0093] Figure 8 A novel method for synthesizing DMT-CPG using p-nitrophenyl (PNP) esters is presented. PNP esters convert an amine-coated surface into a DMT-protected alcohol surface. This method yields stable urea bonds in one step (without EDC coupling). Aminohexanol provides an additional long linker. The DMT-CPG loading can be precisely measured prior to DNA synthesis.

[0094] Figure 9 The DMT-CPG measurement was used to evaluate the coupling efficiency and cutting efficiency of a universal connector.

[0095] Figure 10 The middle diagram illustrates how to use two primers (forward and reverse) to "enclose" the dsDNA amplification region (amplifier). PCR primers must have an unmodified 3' end; otherwise, they will not be extended by Taq polymerase during the polymerase chain reaction.

[0096] Figure 11 This represents simultaneous DNA synthesis using PCR primer pairs. DNA was synthesized as usual using a universal phosphoramide spacer between the primer sequences. Deprotection yielded a 1:1 mixture of primers with unmodified 3'-OH. Primer 1 has a residual 5'-UL fragment, which does not affect PCR performance.

[0097] Figure 12 The kinetics of cleavage of BHQ1 from CPG-UL3-BHQ1 in 1.6% (v / v) TEA:3HF / MeOH at 22 °C (+ / - 0.2 °C), as determined by spectrophotometry, are shown. Detailed Implementation

[0098] Before further describing this subject matter disclosure, it should be understood that this disclosure is not limited to the specific embodiments described below, as these specific embodiments may vary and still fall within the scope of the appended claims. It should also be understood that the terminology used is for the purpose of describing particular embodiments and is not intended to be limiting. Rather, the scope of this disclosure will be established by the appended claims.

[0099] Advantages of this disclosure may include, for example, (1) improved oligonucleotide yield by protecting the secondary hydroxyl group of the universal linker with a silyl group, (2) the single isomer at the secondary hydroxyl carbon allows for easier chemical analysis of the universal linker phosphoramidite because fewer isomers of the phosphoramidite reagent can be present, (3) improved cleavage by using “pre-organized” ortho-iso-oxygen functionalized groups in the universal linker, and (4) reduced labor by automating the synthesis and purification of a 1:1 mixture of primer pairs in a single operation.

[0100] With the introduction of high-throughput DNA synthesizers, the relevance of universal solid supports appears to be more important than ever. Conventional synthesis supports contain adapters to which the first base is attached. For example, the synthesis of oligodeoxyribonucleotides requires four solid supports (A, T, G, C). In contrast, universal solid supports contain universal adapters to which the first base is not attached. Therefore, universal solid supports can allow the use of a single support for all syntheses. Thus, universal adapters can (1) eliminate the need for a list of nucleoside-adaptor-supports, (2) minimize the probability of error in the selection of the correct nucleoside-adaptor-support type, (3) reduce time and eliminate potential errors in the generation of nucleoside-adaptor-support arrays in high-throughput synthesizers, and (4) allow the preparation of an option when a given support may not conventionally provide an oligonucleotide with a 3'-OH terminus for any chosen nucleoside (A, T, G, C).

[0101] This article provides an improved method for synthesizing 3'-unmodified oligonucleotides on a DNA synthesis electrode. The synthesis of 3'-unmodified oligonucleotides is significantly simplified, improving the quality and cleavage efficiency of the synthesized oligonucleotides. The reagents for DNA synthesis described herein contain universal adapters that can be applied to coated electrode surfaces.

[0102] Two different types of universal connectors (see example, Figure 1 This has been commercialized and is sold by Glen Research (Sterling, VA). Both types of linkers have vicinal diol structures that are individually protected as acid-sensitive DMT groups (for oligomer elongation) and base-sensitive acyl groups (for oligomer release during deprotection). In each case, DNA synthesis begins with the dimethoxytriphenylmethyl (DMT) group in the linker structure. Base treatment releases the oligonucleotide with an unmodified 3'-hydroxy terminus (see [link to product]). Figure 2 ).

[0103] The composition and method involve using a universal connector solid support structure comprising a coated platinum electrode, wherein the coated surface is coupled to the universal connector. For connectors with a structure having Universal Support III, deprotection of the dichloroacetyl group on the secondary hydroxyl group with anhydrous ammonia in methanol releases the 3'-unmodified nucleic acid chain for further deprotection and purification. The dichloroacetyl group is highly reactive to bases, but ammonia deprotection also rapidly cleaves the cyanoethyl protecting group from the phosphate ester, yielding a lower yield of the synthetic oligonucleotide released from the electrode surface. The cyanoethyl group can also be selectively removed with tert-butylamine or DBU to immobilize the synthetic oligonucleotide chain to the solid support.

[0104] Although the dichloroacetyl protecting group on the secondary hydroxyl group exhibits good performance in universal support III, competitive hydrolysis of the cyanoethyl group leads to low yields. For example, "universal linker phosphorous amides" have been described in the literature (see Yagodkin, 2009). They used a more stable 2,4-dichloroacetyl protecting group and showed 15%–25% lower yields of released oligonucleotides compared to those using the dichloroacetyl protecting group. In this paper, we disclose that silyl groups (e.g., like TBDMS or TBDPS) can be used to protect the secondary hydroxyl group. This group can be removed with fluoride ions (e.g., like TBAF or TREAT HF), thereby preventing competitive hydrolysis of the cyanoethyl group and yielding higher yields of released oligonucleotides.

[0105] The universal connector can have a conformationally rigid and chemically stable bridgehead epoxy atom carrying a locked-in 4,4′-dimethoxytriphenylmethyl (DMT) and succinyl group (Ravikumar et al., Org. Process Res. Dev. 2008, 12, 3, 399–410). The geometry of the ortho- and iso-oxygen functionalized groups allows for rapid and clean cleavage under standard ammonia deprotection conditions. Figure 3 The study shows that the structure is "pre-organized" using ortho-hydroxy groups on the same side of the rigid ring system. When the base-sensitive succinate linker is hydrolyzed, the 3'-hydroxy oligonucleotide is dephosphorylated and released.

[0106] The methods and systems described herein include a solid support system comprising a combination of coated platinum electrodes and universal connector molecules based on UNYLINKER. TM or UNYSUPPORT TMThe system, represented herein by formula (II), is released with ammonia (Guzaev, 2003, J Am Chem Soc, 125(9):2380-1) or anhydrous methylamine gas (US Patent 7,202,264), the entire contents of each of these references are incorporated herein by reference.

[0107] Methods for synthesizing the universal linker can be found, for example, Guzaev, 2003 and Yagodkin, 2011, each of which is incorporated herein by reference in its entirety, particularly concerning methods for manufacturing universal linker molecules.

[0108] In one embodiment, the linker based on the Universal Support III system originates from the pure (R) or (S)-isomer of 3-amino-1,2-propanediol, such as Figure 4 As shown in the diagram, previous syntheses of the linker system used racemic mixtures of compounds (viscous syrup, bp 264-265 at 739 mm Hg), while the pure isomers were solids (mp 54-56 °C). The inventors used the (R) isomers, which are extremely low-cost, as starting materials for synthesizing the desired linkers. The single stereoisomer on the secondary hydroxyl carbon simplifies the downstream synthesis of many intermediates required for the synthesis of the universal linker phosphorus amide. For example, the universal linker phosphorus amide described herein is a mixture of two diastereomers, while previous efforts yielded a mixture of four diastereomers. Despite some differences in physical properties, the single-isomer universal linker and the mixed isomers exhibit the same behavior for the release of the 3'-OH unmodified oligonucleotide, and we require simultaneous protection of the structures of both the single-isomer and the mixed isomers.

[0109] In one embodiment, the methods and systems provided herein include a solid support system comprising a combination of a coated platinum electrode and a universal connector molecule based on a Universal Support III system. Methods for synthesizing the universal connector can be found, for example, Azhayev, 2001 and Yagodkin, 2011, each of which is incorporated herein by reference, and particularly concerning methods for fabricating the universal connector molecule. As noted above, they use mixed stereoisomers; however, the chemical preparation is similar for individual isomers.

[0110] In one embodiment, the solid support system includes the universal connector shown in formula (I):

[0111]

[0112] Wherein, when A is a connecting portion attached to a coated platinum electrode containing substituted or unsubstituted aliphatic groups, substituted or unsubstituted aliphatic ethers, substituted or unsubstituted heteroalkyl groups, substituted or unsubstituted aromatic groups, or substituted or unsubstituted heterocyclic groups, one of W or Q is a blocking group that can be cleaved under alkaline or neutral conditions, while the other of W or Q is H, or a blocking group that can be cleaved under acidic conditions; or

[0113] Wherein, when A is H, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aliphatic ether, a substituted or unsubstituted heteroalkyl group, a substituted or unsubstituted aromatic group, or a substituted or unsubstituted heterocyclic group, one of Q or W is a cleavable junction portion attached to the coated platinum electrode under alkaline or neutral conditions, and the other of W or Q is H, or a cleavable blocking group under acidic conditions.

[0114] In another embodiment, the solid support system includes the universal connector shown in formula (II):

[0115]

[0116] In another embodiment, the solid support system comprises the universal connector (hybrid isomers and single isomers) shown in formula (III):

[0117]

[0118] in

[0119] R is an alkyl, aryl, heteroalkyl, or heteroaryl group attached to a platinum electrode or other base material;

[0120] A is NH, O, S, alkyl, or aryl;

[0121] X is an acyl, aryl, or silyl group; and

[0122] Y is a dimethoxytriphenylmethyl group or a protecting group that can be removed under acidic conditions.

[0123] In another embodiment, the solid support system includes the universal connector (hybrid stereoisomers and single stereoisomers) shown in formula (IV):

[0124]

[0125] R1 is an alkyl, aryl, heteroalkyl, or heteroaryl group attached to a platinum electrode or other base material.

[0126] In another embodiment, the solid support system comprises a universal connector molecule (a mixture of stereoisomers and a single stereoisomer) as shown in formula (V):

[0127]

[0128] In this embodiment, an amine-containing solid support is treated with an azide to form urea bonds (see [link]). Figure 2 This method has been successfully used in the synthesis of USIII (Yagodkin 2011). During fixation, the dichloroacetyl protecting group may detach, and the published protocol re-capsulates it with dichloroacetic acid activated by 1,1'-carbonyldiimidazole (CDI) before use in DNA synthesis.

[0129] In other embodiments herein, the universal connector is phosphorous amide.

[0130] In another embodiment, the solid support system includes the universal connector (hybrid stereoisomers and single stereoisomers) shown in formula (VI):

[0131]

[0132] in

[0133] A is

[0134] X is an acyl, aryl, or silyl group; and

[0135] Y is a dimethoxytriphenylmethyl group, or a protecting group that can be removed under acidic or neutral conditions.

[0136] In another embodiment, the solid support system comprises a universal connector (a mixture of stereoisomers and a single stereoisomer) as shown in formula (VII). The synthesis is described in... Figure 5 middle.

[0137]

[0138] In other embodiments herein, the universal connector is phosphorous amide.

[0139] In one embodiment, the solid support system includes the universal connector (hybrid stereoisomers and single stereoisomers) shown in formula (VIII):

[0140]

[0141] in

[0142] A is

[0143] X is an acyl, aryl, or silyl group; and

[0144] Y is a dimethoxytriphenylmethyl group, or a protecting group that can be removed under acidic or neutral conditions.

[0145] In another embodiment, the solid support system includes the universal connector (hybrid stereoisomers and single stereoisomers) shown in formula (IX):

[0146]

[0147] The above-described linker structure reveals a previously unreported urethane bond between the aliphatic linker and the protected aminopropylene glycol structure. The synthesis is described in... Figure 6 middle.

[0148] In another embodiment, the solid support system comprises a universal connector (hybrid stereoisomers and a single stereoisomer) as shown in formula (X). The synthesis is described in… Figure 7 middle.

[0149]

[0150] The aliphatic groups described herein may have about 1 to about 10 carbons, about 1 to about 8 carbons, about 2 to about 6 carbons, and may be saturated or unsaturated. Suitable aliphatic groups include, but are not limited to, methane, acetylene, ethylene, ethane, propyne, propylene, propane, 1,2-butadiene, 1-butyne, 1-butene, butane, n-pentyl, nonyl, or combinations thereof.

[0151] The lower alkyl groups described herein may have 1 to 6 carbons. For example, lower alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl, isobutyl, or n-hexyl groups.

[0152] The aromatic organic groups described herein may be cyclic carbon chains, or alternatively, as defined by Hückel's rule. Aromatic organic groups include, but are not limited to, benzene, phenyl groups, aniline, acetophenone, benzaldehyde, benzoic acid, benzyl nitrile, styrene, o-xylene, or combinations thereof.

[0153] The lower alcohol groups mentioned in this article can be water-soluble alcohols, such as methanol, ethanol, and propanol.

[0154] The heteroaromatic groups described herein can be aromatic compounds containing heteroatoms (e.g., O, N, S) as part of a cyclic conjugated ╥ system.

[0155] The heterocyclic groups described herein can be substituted or unsubstituted, and can be cyclic groups having at least two different types of atoms. Heterocyclic groups typically contain carbon and nitrogen, sulfur, or oxygen, and can be 3, 4, 5, 6, 7, or 8-membered rings. Examples of saturated heterocyclic groups include, but are not limited to, azirropropane, ethylene oxide, thiohexacyclopropane, azirrobutane, oxacyclobutane, thiohexacyclobutane, pyrrolidine, oxacyclopentane, thiohexacyclopentane, piperidine, oxacyclohexane, thiohexane, azirroheptane, oxacycloheptane, thiohexacycloheptane, azirrooctane, oxacyclooctane, thiohexaoctane, azirrononane, oxacyclononane, and thiohexacyclononane. Examples of unsaturated heterocyclic groups include, but are not limited to, azirheteropropylene, oxaheteropropylene, thioheteropropylene, azirheterobutadiene, oxaheterobutadiene (ozete), thioheterobutene (thiete), pyrrole, furan, thiophene, pyridine, pyran, thioran, azirheteropropylene, oxaheteropropylene, thioheteropropylene, acridine, oxocine, thiocine, azonine, oxonine, and thionine.

[0156] The nucleoside moiety described herein can be a group formed by losing –OH from a nucleoside molecule. Nucleoside molecules include, but are not limited to, cytidine, uridine, adenosine, guanosine, thymidine, and inosine.

[0157] Oligonucleotide groups can be short DNA or RNA chains. For example, they can be 1-250 nucleotides (or ribonucleotides) in length.

[0158] This document provides methods for synthesizing oligonucleotides on a solid support medium. As used herein, the term "oligonucleotide" has its conventional meaning. In a non-limiting aspect, the term "oligonucleotide" is used generally for polydeoxynucleotides (containing 2-deoxy-D-ribose), polyribonucleotides (containing D-ribose), any other type of polynucleotide that is an N-glycoside of a purine or pyrimidine base, and other polymers containing a non-nucleotide backbone, provided that these polymers contain nucleobases whose conformation allows for base pairing and stacking, as seen in DNA and RNA. It should be understood that, as used herein, the terms "nucleoside" and "nucleotide" will include those portions containing not only known purine and pyrimidine bases, but also modified purine and pyrimidine bases, as well as other modified heterocyclic bases (these portions are sometimes collectively referred to as "purine and pyrimidine bases and their analogues"). Such modifications include methylated purines or pyrimidines, acylated purines or purines, etc. The methods and compositions described herein utilize universal linkers to attach oligonucleotides to a solid support, wherein non-nucleoside linkers are attached to the solid support material. This method allows the use of the same solid support, regardless of the sequence of the oligonucleotide to be synthesized.

[0159] Novel universal linker phosphoridamide (ULP) reagents are described, which can be applied to coated platinum electrodes to allow the synthesis of 3'-unmodified nucleic acid chains. Examples of ULPs, as illustrated herein, are shown in formulas (VII), (VIII), (IX), and (X), and can be prepared using the methods described herein. Universal linker phosphoridamides are related to standard nucleotide phosphoridamides disclosed, for example, by Caruthers et al. (US Patent Nos. 4,415,732, 4,458,066, 4,500,707, 4,668,777, 4,973,679, and 5,132,418), the entire contents of which are incorporated herein by reference.

[0160] The sensitivity of the dichloroacetic acid (DCA) protecting group in the ULP structure can lead to synthetic difficulties. For example, an initial attempt to couple a linker azide (formula V) to 1-amino-6-hexanol to generate a urea bond, as described in U.S. Patent 8,779,194 (incorporated herein by reference in its entirety), was unsuccessful because the DCA group could not be present under the coupling conditions. As described herein, the inventors have discovered that silyl groups (such as tert-butyldimethylsilyl (TBDMS)) can be used to protect the primary alcohol group in an earlier step and can be removed in the final reaction step with a fluoride reagent (such as aqueous tetrabutylammonium fluoride (TBAF)) before conversion to phosphorous amide. This method yields high yields and allows for the synthesis of target ULPs, such as in Figure 5 It is displayed in the middle.

[0161] Although 1-amino-6-hexanol is mainly used due to its commercial availability. Figure 5 The process described herein is not limited to this adapter. Any suitable adapter can be used. Other alkyl lengths and structures can be present in the adapter between the reactive phosphoramidite (at the primary hydroxyl group) and the aminopropylene glycol trigger (DMT-protected). For example, aryl or heteroaryl groups can be present in the adapter, as long as these groups are not reactive in the DNA synthesis coupling cycle. Figure 6 and 7 In other ULPs described herein, the choice of the linker between the imide group and the aminopropylene glycol trigger is also adjustable.

[0162] exist Figure 5The synthesis process shown in the diagram uses TBDMS to protect the primary hydroxyl group because it can be removed by treatment with a fluorinated reagent (like TBAF). Other silyl protecting groups (e.g., TBDPS) can be used instead of TBDMS. Similarly, other fluorinated deprotecting agents are available and can be used instead of TBAF. In any case, the removal of the silyl protecting group must not affect the acid-sensitive DMT group and the base-sensitive DCA group. Other hydroxyl protecting groups (like, for example, benzyl) can be used and removed under mild hydrogenation conditions. Figure 6 and 7 In other ULPs described herein, the choice of protecting group on the primary hydroxyl group is also adjustable.

[0163] In one embodiment, the desired phosphoramidite is selected from... Figure 5 The formula shown in the image.

[0164] In one embodiment, a method for generating a ULP (such as the ULP according to formula (VII)) is provided, wherein 1-amino-6-hexanol is reacted with p-nitrophenyl chloroformate (4-NPC), and the primary alcohol is further protected with TBDMS. The resulting compound is then coupled to a connector amine 3 (structure shown in...). Figure 4 (In the middle) to obtain TBDMS-protected urea. S-isomers or racemic mixtures of aminopropylene glycol-linked amine 3 can also be used, and may have cyclization and cleavage rates comparable to the R-isomers. For S-isomers, only the optical activity of the compounds is opposite, and racemic compounds are not optically active. In any case, the presence of urea, amide, or carbamate protons is required to promote hydrolysis after DCA triggering. Figure 2 The rearrangement described herein. DCA esters can be formed, for example, by activation with a carbonyl diimidazole as previously described (Yagodkin 2011). Other methods for introducing DCA esters are possible, but we have found the CDI method convenient and yielding good yields on a reasonable scale. Finally, the TBDMS group is removed with TBAF, and the alcohol is phosphorylated to obtain the desired phosphoramidite (e.g., ULP 1). An exemplary process for generating ULP 1 according to this embodiment is shown below. Figure 5 middle.

[0165] In another embodiment, a method for generating a ULP (such as the ULP according to formula (IX)) is provided, wherein a TBDPS-protected 1,6-hexanediol is first prepared and activated with p-nitrophenyl chloroformic acid (4-NPC). The resulting compound is then coupled with a linker amine 3 to obtain a TBDPS-protected carbamate. An S-isomer or racemic mixture of aminopropylene glycol linker amine 3 may also be used, and may have cyclization and cleavage rates comparable to the R-isomer. DCA esters can be formed, for example, by activation with a carbonyl diimidazole, but other methods are possible. Finally, the TBDPS group is removed with TBAF, and the alcohol is phosphorylated to obtain the desired phosphoramidite (e.g., ULP 2). An exemplary process for generating ULP 2 according to this embodiment is shown. Figure 6 middle.

[0166] In another embodiment, a method for generating a ULP (such as the ULP according to formula (X)) is provided, wherein a fluoride-triggered silyl protecting group is used instead of a base-triggered DCA protecting group to prepare the ULP (e.g., ULP3). According to this embodiment, the synthesis begins with (R)aminopropanediol, such as... Figure 4 The process is shown, but TBDMS-Cl is used to protect the secondary hydroxyl group (66% yield in 3 steps). The trifluoroacetamide protecting group is then removed with ammonium hydroxide. A urea bond is generated by the reaction of an amine with 6-aminohexanol activated by p-nitrophenyl chloroformate (4-NPC). The primary alcohol is directly phosphorylated to obtain the desired phosphorylate (e.g., ULP 3). An exemplary process for generating ULP 3 according to this embodiment is shown. Figure 7 middle.

[0167] Any support material suitable for oligonucleotide synthesis can be used in this invention. For example, solid supports can be beads, granules, plates, dip rods, bars, membranes, filters, fibers (e.g., optical or glassy), semiconductor devices, or any other suitable form. Other suitable solid supports include materials including, but not limited to, borosilicate glass, agarose, agarose gel, magnetic beads, polystyrene, polyacrylamide, membranes, silica, semiconductor materials, silicon, organic polymers, ceramics, glass, metals, plastic polycarbonate, polycarbonate, polyethylene, polyethylene terephthalate, polymethyl methacrylate, polypropylene, polyvinyl acetate, polyvinyl chloride, polyvinylpyrrolidone, and soda-lime glass. The matrix can take the form of beads, boxes, columns, cylinders, disks, dishes (e.g., glass dishes, Petri dishes), fibers, membranes, filters, microtiter plates (e.g., 96-well microtiter plates), multi-bladed rods, meshes, pellets, plates, rings, rods, rollers, plates, glass slides, rods, trays, tubes, or vials. The matrix can be a single discrete body (e.g., a single tube, a single bead), any number of multiple matrix bodies (e.g., a rack of 10 tubes, several beads), or combinations thereof (e.g., a tray containing multiple microtiter plates, a column filled with beads, a microtiter plate filled with beads).

[0168] The material composition of the solid support material can be any suitable material, such as polymers or silica-based support materials. Specific examples include plastics, nylon, glass, silica, metals, metal alloys, polyacrylamide, polyacrylates, polystyrene, cross-linked dextran, and combinations thereof.

[0169] solid support

[0170] On one hand, support materials for oligonucleotide synthesis can comprise flat (planar) electrodes. Depending on the orientation of the grooved electrodes, the flat electrodes generate either a divergent field or a uniform field. The flat electrodes can be oriented with their grooved sides facing each other to generate a divergent field for electrocellular fusion. Alternatively, they can be oriented with their flat sides facing each other to provide a uniform field for electroporation.

[0171] A flat electrode can be a dense electrode array comprising multiple units and surfaces, wherein each of the multiple units includes an anode and a circumferential cathode, wherein each of the anodes is an individually addressable electrode, and wherein a porous reactive layer is adsorbed onto the surface.

[0172] Electrode array devices can be fabricated using standard CMOS technology. These devices utilize an alternating array of ring-shaped active electrodes and continuous circumferential counter electrodes. In CMOS processes, semiconductor silicon wafers are fabricated using aluminum wiring and electrodes, followed by "post-processing" by sputtering another metal. In some embodiments, the metal is platinum.

[0173] Another form is a standard electrode array device made of ring-shaped electrodes arranged in rows and columns, each “cell” of the electrode array being separated by a line. A cell includes an electrode and associated circuitry required to independently and electronically access each electrode individually. In some embodiments, the lines separating each cell can be raised to the surface of the electrode array (where the electrodes have surface exposure) and function as a counter-electrode network across the array, with each electrode switched on in each electrochemical synthesis step.

[0174] Oligonucleotide synthesis can be performed on a support medium containing multiple individually addressable platinum electrodes. The electrodes can be coated with aryl diazonium salts. Aryl diazonium salts are derived from the general formula R-Ar-N2. + X - This indicates that R can be any organic group, such as alkyl or aryl, and X is an inorganic or organic anion, such as a halogen or tetrafluoroborate. The term "halogen" means chlorine, fluorine, bromine, or iodine. In one embodiment, a carboxylic acid coating can be applied to the electrode surface using a diazonium salt of aminophenylacetic acid (APA) and electrochemical reduction (also known as electrodeposition or electrografting). Similar chemistry for coating gold electrodes with phenylethanol groups for DNA synthesis has been described (Levrie, 2018, Jpn. J. Appl. Physics, 04FM01, which is incorporated herein by reference in its entirety).

[0175] Oligonucleotide synthesis

[0176] Standard methods for the synthesis of oligonucleotides are known in the art (e.g., U.S. Patent Nos. 5,750,666, 6,111,086, 6,008,400, and 5,889,136), each of which is incorporated herein by reference in its entirety.

[0177] Support-bound oligonucleotide synthesis relies on the sequential addition of nucleotides to one end of the growth chain. In this invention, the universal linker described herein is reacted onto a solid surface support (e.g., platinum coated with an amine) for oligonucleotide synthesis. Typically, a first nucleoside (having a protecting group on any exocyclic amine functional group present) is attached to the solid support medium, and an activated phosphite compound (which also has a suitable protecting group) is added stepwise to extend the growth of the oligonucleotide. Further methods for solid-phase synthesis can be found in U.S. Patents to Caruthers 4,415,732, 4,458,066, 4,500,707, 4,668,777, 4,973,679, and 5,132,418, and U.S. Patent to Koster 4,725,677, the entire contents of each of which are incorporated herein by reference.

[0178] By applying a sufficient potential to a selected electrode, an electrochemical reagent capable of electrochemically removing protecting groups from chemical functional groups on a molecule is generated at the selected electrode. When the chemical reagent generated by the electrode acts to deprotect or remove, for example, acid- or base-instable protecting groups from the selected molecule, the removal or "deprotection" of the protecting group according to the invention occurs at the selected molecule. Silicyl protecting groups can be deprotected using a fluoride ion source. Therefore, in some embodiments, the chemical reagent is a fluoride reagent. Examples of suitable fluoride reagents include, but are not limited to, tetrabutylammonium fluoride (TBAF) and pyridine (HF). x Triethylamine trifluoride (TREAT HF), hydrofluoric acid, tris(dimethylamino)difluorotrimethylsilicate (TASF), and ammonium fluoride.

[0179] In one embodiment of the invention, a terminal or linker molecule of a monomeric nucleotide (i.e., a molecule that “links”, for example, a monomer or nucleotide to a matrix) is provided, protected by a protecting group removable by an electrochemically generated reagent. One or more protecting groups are exposed to an electrochemically generated reagent at an electrode and removed from the monomer, nucleotide, or linker molecule in a first selected region to expose reactive functional groups. The matrix is ​​then contacted with a first monomer or pre-formed molecule bonded to the exposed one or more functional groups. The first monomer or pre-formed molecule may also possess at least one protected chemical functional group removable by the electrochemically generated reagent.

[0180] As used herein, the term "protecting group" (or "blocking group") refers to an unstable chemical moiety known in the art that is used to protect hydroxyl, amino, or thiol groups from unwanted reactions during the synthetic process. Protecting groups known in the art are generally described in TH Greene and PGM Watts, 1999, Protective Groups in Organic Synthesis, 3rd Edition, John Wiley & Sons, New York. Examples of hydroxyl protecting groups include, but are not limited to, benzyloxycarbonyl, 4-nitrobenzyloxycarbonyl, 4-bromobenzyloxycarbonyl, 4-methoxybenzyloxycarbonyl, methoxycarbonyl, tert-butoxycarbonyl (BOC), isopropoxycarbonyl, diphenylmethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 2-(trimethylsilyl)ethoxycarbonyl, 2-furfuryloxycarbonyl, allyloxycarbonyl (Alloc), acetyl (Ac), formyl, chloroacetyl, trifluoroacetyl, methoxyacetyl, phenoxyacetyl, benzoyl (Bz), methyl, tert-butyl, 2,2,2-trichloroethyl, 2- Trimethylsilylethyl, 1,1-dimethyl-2-propenyl, 3-methyl-3-butenyl, allyl, benzyl (Bn), p-methoxybenzyl diphenylmethyl, triphenylmethyl (triphenylmethyl), 4,4'-dimethoxytriphenylmethyl (DMT), substituted or unsubstituted 9-(9-phenyl)xanthanyl, tetrahydrofuranyl, methoxymethyl, methylthiomethyl, benzyloxymethyl, 2,2,2-trichloroethoxymethyl, 2-(trimethylsilyl)ethoxymethyl, methanesulfonyl, p-toluenesulfonyl, trimethylsilyl, triethylsilyl, and triisopropylsilyl. In some embodiments, the protecting group is DMT.

[0181] In some embodiments, the hydroxyl protecting group is a silyl protecting group. Examples of silyl protecting groups include, but are not limited to, 2-(trimethylsilyl)ethoxycarbonyl, 2-trimethylsilylethyl, 2-(trimethylsilyl)ethoxymethyl, trimethylsilyl (TMS), triethylsilyl (TES), triisopropylsilyl (TIPS), isopropyl dimethylsilyl (IPDMS), diethylisopropylsilyl (DEIPS), tert-butyl dimethylsilyl (TBS), tert-butyl diphenylsilyl (TBDPS), tetraisopropyldisiloxyalkyl (TIPDS), di-tert-butylsilyl (DTBS), and tert-butyl dimethylsilyl (TBDMS).

[0182] The monomer or preformed molecule can then be deprotected in the same manner to obtain a second set of reactive chemical functional groups. The second monomer or preformed molecule is then contacted with a matrix to bond with the second set of exposed functional groups; this second monomer or preformed molecule may also possess at least one protecting group removable by an electrochemically generated reagent. Any unreacted functional groups can optionally be end-capped at any point during the synthesis process. The deprotection and bonding steps can be repeated sequentially at this site on the matrix until a polymer or oligonucleotide with the desired sequence and length is obtained.

[0183] A matrix bonded with one or more molecules possessing at least one protected chemical functional group may be located near an electrode array in contact with a buffer or scavenging solution. After applying a potential sufficient to generate an electrochemical reagent capable of deprotecting the protected chemical functional groups to selected electrodes in the array, the molecules near these selected electrodes are deprotected to expose reactive functional groups, thus preparing them for bonding. A monomer solution or a solution of pre-formed molecules (such as proteins, nucleic acids, polysaccharides, and porphyrins) is then contacted with the matrix surface, and these monomers or pre-formed molecules are bonded to the deprotected chemical functional groups.

[0184] The method described herein may further include reacting the monomer-functionalized support medium with a capping agent; and optionally treating the monomer-functionalized support medium with an oxidizing agent.

[0185] After oligonucleotide synthesis, the oligonucleotide can be released from or immobilized onto a solid support medium. These methods may include treating the oligonucleotide with a reagent that effectively cleaves the oligonucleotide from the support medium, preferably from a linker attached to the support medium. In some such embodiments, treatment with a reagent that effectively cleaves the oligonucleotide removes protecting groups present on the oligonucleotide. In some embodiments, the cleaved oligonucleotide has an unmodified 3' terminal hydroxyl group at the cleavage site. In several embodiments, the solid support medium is treated with anhydrous ammonia for a time sufficient to cleave the oligonucleotide.

[0186] The cleaved oligonucleotide can then be prepared using procedures known in the art, such as size exclusion chromatography, high-performance liquid chromatography (e.g., reversed-phase HPLC), differential precipitation, etc. In some embodiments according to the invention, the oligonucleotide is cleaved from a solid support medium while the 5'-OH protecting group remains on the final nucleoside. This so-called DMT-modified (or trimethyl-on) oligonucleotide is then subjected to chromatography, followed by removal of the DMT group by treatment in an organic acid, and then desalting and further purification of the oligonucleotide to form the final product.

[0187] In some embodiments, the immobilized oligonucleotides can be prepared using the universal support linker system described herein. The oligonucleotide-bound support structure is first treated for 1 hour with a 20% solution of tert-butylamine in acetonitrile (Chang and Horn, 1999; Nucleosides and Nucleotides, 2006; pp 1205-6) to remove cyanoethyl groups and acrylonitrile byproducts. The resulting phosphate diester is stable and does not cleave when the hydrolyzed dichloroacetate group is treated with ammonia or AMA (1:1, 37% ammonium hydroxide: 40% methylamine) (see, for example...). Figure 3 After the protecting groups are cleaved, the chip is washed, and the oligonucleotides remain immobilized on the electrodes.

[0188] Uses of oligonucleotides

[0189] The methods and compositions provided herein can be used for genome editing libraries (such as CRISPR gRNA and shRNA screening libraries), targeted sequencing (such as hybridization capture or molecular inversion probes (MIPs), mutagenesis libraries, generation of oligonucleotides for in situ hybridization applications, and generation of oligonucleotide pools for DNA data storage.

[0190] A common application of automated DNA synthesis is for generating PCR primers. PCR uses a pair of custom primers to guide DNA to extend towards each other at opposite ends of the sequence being amplified. These primers are typically 18 to 24 bases long and should encode only specific upstream and downstream sites of the sequence being amplified, such as... Figure 10 It is displayed in the middle.

[0191] like Figure 11 As shown in the paper, the universal linker phosphoramide described herein can be used to prepare two primers in a single synthetic column. Figure 11 The process shows that ULP introduces a spacer between the DNA sequences of primer 1 and primer 2. After trimethyl-demethylated DNA synthesis, the solid support can be treated with 4M ammonia / MeOH. The primer 1 sequence is released from the solid support, typically by cleaving the universal adapter spacer to obtain the primer 2 sequence with the 3'-hydroxyl group. The protecting group is removed with ammonia or AMA to produce a 1:1 mixture of primers 1 and 2. Evaporation leaves the 1:1 mixture of primers, along with contaminated ineffective sequences and the removed protecting groups.

[0192] Typically, PCR primers are purified by removing the 5'-triphenylmethyl group from the oligomers and simply "desalting" them using a gel filtration column. Gel filtration separates the components of a mixture based on molecular size and is one of the simplest chromatographic forms for oligonucleotide purification. Cleavage protecting groups and truncated sequences remain in the gel matrix, while larger oligonucleotide molecules rapidly elute through the gel filtration column. Since primers 1 and 2 are approximately the same length, they elute with the same fraction. The concentration of the 1:1 primer mixture is determined by absorbance at 260 nm using the combined extinction coefficient of the two oligomers. The 1:1 mixture can be used directly for PCR without having to separately dissolve the two oligomers, determine the concentration of each primer, calculate the volume of each primer to achieve a 1:1 mixture, transfer and mix the required volume, and re-dry the mixture. Therefore, significant labor is saved by automating the synthesis and purification of a 1:1 mixture of the two primers in a single operation.

[0193] Using phosphoramide, DNA synthetic molecules can be synthesized on the surface of a solid support matrix in a stepwise reaction process, typically in the 3' to 5' direction, and this stepwise reaction process consists of: (1) a detrimethylation step to remove the protecting group from the previously added nucleoside, (2) coupling of the next nucleoside with the grown DNA oligomer, (3) oxidation to convert the phosphite intermediate into a more stable phosphotriester, and (4) irreversible capping of any unreacted 5' hydroxyl groups. Unbound by theory, capping of unreacted 5' hydroxyl groups can help prevent the synthesized sequence from having deletions relative to the pre-selected nucleic acid sequence by avoiding further polymerization from such 3' hydroxyl groups in subsequent cycles. This cycle can be repeated to add the next base. Solid supports can comprise a variety of units, such as beads, including but not limited to highly porous polymer beads; glass or silica beads, including but not limited to fused silica (amorphous pure silica), quartz (crystalline pure silica), metals (titanium, such as titanium nitride or platinum), or any other suitable beads described herein or otherwise known in the art that can be packed into cavities or columns into which synthetic reagents are delivered. Using microfluidic methods, the methods, apparatuses, and compositions described herein can be used to scale up nucleic acid synthesis methods.

[0194] Detrimethylated oligonucleotide synthesis refers to the use of a 5'-O'-triphenylmethyl group to protect the 5'-hydroxy group of the target oligonucleotide during the coupling and oxidation steps. After synthesis, the triphenylmethyl group can be cleaved from the target oligonucleotide (e.g., "detrimethylated sequence") with an acid.

[0195] Acidic conditions may include pH values ​​of about 1 to about 6.9, about 2 to about 6.9, about 3 to about 6.9, about 4 to about 6.9, about 5 to about 6.9, and about 6 to about 6.9.

[0196] Neutral conditions may include pH values ​​of about 6.9 to about 7, about 7, about 7 to about 7.1, about 7 to about 7.2, about 7 to about 7.3, about 7 to about 7.4, and about 7 to about 7.5.

[0197] definition

[0198] "Phosphosphonamide" (RO)₂PNR₂ refers to the monoamide of a phosphite diester. Characteristics of phosphorusamides may include their high reactivity with nucleophiles catalyzed by weak acids (e.g., triethylammonium chloride or 1H-tetrazole). In these reactions, the incoming nucleophile can replace the NR₂ moiety.

[0199] "Aliphatic" refers to open-chain hydrocarbon groups, whether straight-chain or branched, that do not contain any type of ring or cyclic hydrocarbon groups (if they are not aromatic).

[0200] "Aliphatic ethers" refer to ethers in which the ether group in the molecule does not have an aryl group.

[0201] "Aromatic" refers to monocyclic and polycyclic aromatic hydrocarbon groups.

[0202] An "acyl" group is a moiety derived from an oxyacid (including inorganic acids) by removing one or more hydroxyl groups. It can contain a double-bonded oxygen atom and an alkyl group (RC=O).

[0203] "Aromatic acyl group" refers to any monovalent group R-CO- derived from aromatic carboxylic acids.

[0204] "Ortho-diol" refers to two hydroxyl groups occupying the adjacent position, that is, they are attached to the adjacent atom.

[0205] "Alkyl" refers to a straight-chain or branched hydrocarbon group consisting only of carbon and hydrogen atoms, which is unsaturated, has one to twelve carbon atoms (preferably one to eight or one to six carbon atoms), and is attached to the rest of the molecule by a single bond, such as methyl, ethyl, n-propyl, 1-methylethyl (isopropyl), n-butyl, n-pentyl, 1,1-dimethylethyl (tert-butyl), etc.

[0206] "Heteroalkyl" refers to an alkyl group substituted with one or more of the following groups: alkyl, alkenyl, halogenated, haloalkyl, cyano, aryl, cycloalkyl, heterocyclic, heteroaryl, -OR 14 —OC(O)—R 14 —N(R) 14 )2、—C(O)R 14 —C(O)OR 14 —C(O)N(R) 14 )2、—N(R 14 )C(O)OR 16 —N(R)14 )C(O)R 16 —N(R) 14 (S(O)) t R 16 (where t is 1 to 2), —S(O) t OR 16 —SR 16 (where t is 1 to 2), —S(O) t R 16 (where t is between 0 and 2), and —S(O) t N(R 14 )2 (where t is 1 to 2), where each R 14 Independently, it is hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl; and each R 16 It is an alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl.

[0207] "Aryl" refers to an aromatic monocyclic or polycyclic hydrocarbon ring system consisting only of hydrogen and carbon and containing six to nineteen carbon atoms (preferably six to ten carbon atoms), wherein the ring system may be partially saturated. Aryl groups include, but are not limited to, groups such as fluorenyl, phenyl, and naphthyl. Unless otherwise specified in the specification, the term "aryl" or the prefix "ar-" (as in "arylalkyl") means an aryl group including those optionally substituted with one or more substituents selected from the group consisting of: alkyl, alkenyl, ynyl, halogenated, haloalkyl, cyano, nitro, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclic, heterocyclic alkyl, heteroaryl, heteroarylalkyl, -R 15 —OR 14 —R 15 —OC(O)—R 14 —R 15 —N(R 14 )2、—R 15 —C(O)R 14 —R 15 —C(O)OR 14 —R 15 —C(O)N(R 14 )2、—R 15 —N(R 14 )C(O)OR 16 —R 15 —N(R 14 )C(O)R 16 —R 15 —N(R 14 (S(O)) t R 16(where t is 1 to 2), —R 15 —S(O) t OR 16 (where t is 1 to 2), —R 15 —SR 16 —R 15 —S(O) t R 16 (where t is 0 to 2), and —R 15 —S(O) t N(R 14 )2 (where t is 1 to 2), where each R 14 Independently, each R is hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl; 15 Independently, it is a direct bond or a straight-chain or branched alkylene or alkenylene chain; and each R 16 It is an alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl.

[0208] "Heterocyclic group" refers to a stable 3- to 18-membered non-aromatic cyclic group consisting of a carbon atom and one to five heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur. For the purposes of this invention, the heterocyclic group can be a monocyclic, bicyclic, or tricyclic ring system, which may include fused or bridged ring systems, and may be partially unsaturated; and the nitrogen, carbon, or sulfur atom in the heterocyclic group may optionally be oxidized; the nitrogen atom may optionally be alkylated / substituted; and the heterocyclic group may be partially or fully saturated. Examples of such heterocyclic groups include, but are not limited to, dioxacyclopentyl, decahydroisoquinolinyl, imidazolinyl, imidazoalkyl, isothiazolyl, isoxazolyl, morpholinyl, octahydroindolyl, octahydroisoindolyl, 2-oxopiperidinyl, 2-oxopiperidinyl, 2-pyrrolidinyl, oxazolyl, piperidinyl, piperazinyl, 4-piperidinoneyl, pyrrolidinyl, pyrazolyl, thiazoalkyl, tetrahydrofuranyl, trithiadinyl, tetrahydropyranyl, thiomorpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl and 1,1-dioxo-thiomorpholinyl, homopiperidinyl, homopiperazinyl and quininecycloyl. Unless otherwise specified in the specification, the term "heterocyclic" means a heterocyclic group, as defined above, optionally substituted with one or more substituents selected from the group consisting of: alkyl, alkenyl, halogenated, haloalkyl, cyano, oxo, thio, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclic, heterocyclic alkyl, heteroaryl, heteroarylalkyl, -R 15 —OR 14 —R 15 —OC(O)—R 14 —R 15 —N(R14 )2—R 15 —C(O)R 14 —R 15 —C(O)OR 14 —R 15 —C(O)N(R 14 )2、—R 15 —N(R 14 )C(O)OR 16 —R 15 —N(R 14 )C(O)R 16 —R 15 —N(R 14 (S(O)) t R 16 (where t is 1 to 2), —R 15 —S(O) t OR 16 (where t is 1 to 2), —R 15 —SR 16 —R 15 —S(O) t R 16 (where t is 0 to 2), and —R 15 —S(O) t N(R 14 )2 (where t is 1 to 2), where each R 14 Independently, each R is hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl; 15 Independently, it is a direct bond or a straight-chain or branched alkylene or alkenylene chain; and each R 16 It is an alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl, and each of the above substituents is unsubstituted.

[0209] "Heteroaryl" refers to a 5- to 18-membered aromatic ring group, which consists of a carbon atom and one to five heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur. For the purposes of this invention, the heteroaryl group can be a monocyclic, bicyclic, or tricyclic ring system, which may include fused or bridged ring systems, and may be partially saturated; and the nitrogen, carbon, or sulfur atom in the heteroaryl group may optionally be oxidized; the nitrogen atom may optionally be alkylated / substituted. Examples include, but are not limited to, azirrolyl, acridine, benzimidazolyl, benzothiazolyl, benzoindolyl, benzothiadiazolyl, benzonaphthuronyl, benzooxazolyl, benzodioxane-pentenyl, benzodioxinyl, benzopyranyl, benzopyranonyl, benzofuranyl, benzofuranonyl, benzothiophenyl, benzothiophenyl, benzotriazolyl, benzo[4,6]imidazo[1,2-a]pyridyl, carbazole, cinnolinyl, dibenzofuranyl, furanyl, furanonyl The following groups are listed: yl, isothiazolyl, imidazolyl, indolyl, indazole, isoindolyl, indololinyl, isoindololinyl, inazinyl, isoxazolyl, naphridinyl, oxadiazolyl, 2-oxozazolyl, oxazolyl, phenazinyl, phenothiazinyl, phenothiazinyl, phthalazinyl, pteridinyl, purine, pyrroleyl, pyrazolyl, pyridinyl, pyridinyl, pyrimidinyl, pyridazinyl, quinazolinyl, quinoxolinyl, isoquinolinyl, thiazolyl, thiadiazolyl, triazolyl, tetrazolyl, triazinyl, and thiophenyl. Unless otherwise specified in the specification, the term "heteroaryl" means a heteroaryl group comprising, as defined above, optionally substituted with one or more substituents selected from the group consisting of: alkyl, alkenyl, ynyl, halogen, haloalkyl, cyano, oxo, thio, nitro, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, heterocyclic, heterocyclic alkyl, heteroaryl, heteroaryl, heteroarylalkyl, -R 15 —OR 14 —R 15 —OC(O)—R 14 —R 15 —N(R 14 )2、—R 15 —C(O)R 14 —R 15 —C(O)OR 14 —R 15 —C(O)N(R 14 )2、—R 15 —N(R 14 )C(O)OR 16 —R 15 —N(R 14 )C(O)R 16 —R 15 —N(R 14 (S(O)) t R 16 (where t is 1 to 2), —R 15—S(O) t OR 16 (where t is 1 to 2), —R 15 —SR 16 —R 15 —S(O) t R 16 (where t is 0 to 2), and —R 15 —S(O) t N(R 14 )2 (where t is 1 to 2), where each R 14 Independently, each R is hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl; 15 Independently, it is a direct bond or a straight-chain or branched alkylene or alkenylene chain; and each R 16 It is an alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclic, heterocyclic alkyl, heteroaryl, or heteroarylalkyl.

[0210] "Silyl ethers" refer to a group of chemical compounds containing silicon atoms covalently bonded to an alkoxy group. The general structure is R1R2R3Si-O-R4, where R4 is an alkyl or aryl group. Because R1R2R3 can be a combination of different groups, it can be varied to provide a wide range of silyl ethers, thus offering broad selectivity for protecting group chemistry. Silyl ethers can include, but are not limited to, trimethylsilyl (TMS), triethylsilyl (TES), tert-butyldiphenylsilyl (TBDPS), tert-butyldimethylsilyl (TBS / TBDMS), and triisopropylsilyl (TIPS).

[0211] Example

[0212] Example 1: Diverse and universal adapter cleavage after DNA synthesis

[0213] Following DNA synthesis, the universal connector structure can be cleaved from the electrode surface using 4-9M ammonia in anhydrous methanol (for ULP1 and ULP2) or 1.6% (v / v) TEA:3HF in anhydrous methanol (for ULP3). Alternatively, as in Figure 2 As shown for ULP1 and ULP3, the universal connector can be fixed to the surface using 20% ​​tert-butylamine or 10% 1,8-diazabicyclo(5.4.0) undec-7-ene (DBU) in acetonitrile (ACN).

[0214] Treatment of ULP1 and ULP2 with anhydrous ammonia in methanol rapidly cleaves the dichloroacetyl group and dephosphorylates to release oligomers. Treatment of ULP3 with TEA:3HF cleaves the TMDMS protecting group, which also leads to dephosphorylation and oligomer release. Treatment of ULP1, ULP2, and ULP3 with tert-butylamine or DBU in ACN rapidly cleaves the cyanoethyl group and immobilizes the oligonucleotides to the surface.

[0215] After releasing the oligonucleotides from the support, the solution was removed from the solid support and combined with ammonia (37%) or AMA (1:1, 37% ammonium hydroxide: 40% methylamine) in a screw-capped tube. After heating, the completely deprotected oligonucleotides were dried under vacuum and purified using standard methods.

[0216] For the immobilized oligonucleotides, the solid support was first treated for 1 hour with a 20% solution of tert-butylamine in acetonitrile (see, for example, Chang and Horn, 1999; Nucleosides and Nucleotides, 2006, pp. 1205-6) to remove the cyanoethyl groups and acrylonitrile byproducts. The resulting phosphate diester was stable and did not cleave when treated with ammonia or AMA to hydrolyze the dichloroacetate groups. After the cleavage of the protecting groups was complete, the solid support was washed, and the oligonucleotides remained immobilized on the electrode.

[0217] Example 2: Linker amine 3(R) isomer

[0218] Using a modified publication procedure for racemic mixtures, the connector amine 3 ( Figure 4 (R)-3-amino-1,2-propanediol was isolated as a single stereoisomer (see, for example, Azhayev, 2001). Following trifluoroacetamide protection of methyl trifluoroacetate, the product was reacted in pyridine with a limited amount of dimethoxytriphenylmethyl chloride. Since excess trifluoroacetate was readily washed away with water, the product was easily separated by extraction. After deprotection with ammonium hydroxide, trace impurities were removed by precipitation from hexane to give (R)-synthetic amine 3 as a white solid in 91% yield. Racemic mixtures were previously reported as colorless syrups. Intermediate compounds generated during the preparation of synthetic amine 3 ( Figure 4 As shown below:

[0219] 1. (R)-N-(2,3-dihydroxypropyl)-2,2,2-trifluoroacetamide. (MW 187.12) 1 H NMR (CD3CN)

[0220] 2. (R)-N-(3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropyl)-2,2,2-trifluoroacetamide (MW 489.48)

[0221] 3. (R)-1-Amino-3-(bis(4-methoxyphenyl)(phenyl)methoxy)prop-2-ol (MW 393.48)

[0222] Example 3: Universal Connector Phosphite (Urea Bond) – ULP 1

[0223] The sensitivity of the dichloroacetic acid (DCA) protecting group in the ULP structure hinders synthesis. We found that tert-butyldimethylsilyl (TBDMS) can be used to protect the primary alcohol group in an early step and can be removed by aqueous tetrabutylammonium fluoride (TBAF) in the final reaction step before conversion to phosphorous amide. This method yields high yields and allows for the synthesis of... Figure 5 The target ULP is shown in the image. We first tried the more stable tert-butyldiphenylsilyl (TBDPS), such as... Figure 6 The data shows that TBDPS is feasible, but the reaction time in aqueous tetrabutylammonium fluoride (TBAF) is relatively long, causing some hydrolysis of DCA.

[0224] As described in U.S. Patent 8,779,194, we first attempted to couple the linker azide (structure V) with 1-amino-6-hexanol to generate a urea bond. However, we found that the dichloroacetyl group could not be present under the coupling conditions. Instead, we reacted 1-amino-6-hexanol with p-nitrophenyl chloroformate (4-NPC) and further protected the primary alcohol with TBDMS. This compound was then coupled to linker amine 3 (structure shown in...). Figure 4 (in the middle) to obtain TBDMS-protected urea. A DCA ester was formed by activation with carbonyl diimidazole as previously described (Yagodkin 2011). Finally, the TBDMS group was removed with TBAF, and the alcohol was phosphorylated to obtain the desired phosphoramidide (ULP 1). An intermediate compound generated during the preparation of ULP 1 ( Figure 5 As shown below:

[0225] 1,6-(tert-butyldimethylsilyloxy)hexylcarbamate 4-nitrophenyl ester

[0226] 2.(R)-1-(3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropyl)-3-(6-(tert-butyldimethylsilyloxy)hexyl)urea

[0227] 3.(R)-1,1-bis(4-methoxyphenyl)-16,16,17,17-tetramethyl-7-oxo-1-phenyl-2,15-dioxa-6,8-diaza-16-silazoctadecane-4-yl 2,2-dichloroacetate

[0228] 4.(R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-(3-(6-hydroxyhexyl)ureido)propyl-2-yl 2,2-dichloroacetic acid ester

[0229] Example 4: Universal Connector Phosphite (Carbamate Bond) – ULP2

[0230] ULP2 with a carbonate structure was prepared using a scheme similar to that described in Example 3 (see [link]). Figure 6 In this example, 1,6-hexanediol protected by TBDPS was first prepared and activated with p-nitrophenyl chloroformate (4-NPC). This compound was then coupled with a linker amine 3 to obtain a TBDMS-protected carbamate. Activation with carbonyl diimidazole, as commonly used, formed a DCA ester. Finally, the TBDPS group was removed with TBAF, and the alcohol was phosphorylated to obtain the desired phosphoridamide (ULP2). An intermediate compound generated during the preparation of ULP2 (…) Figure 6 As shown below:

[0231] 1,6-(tert-butyldiphenylsilyloxy)hex-1-ol

[0232] 2,6-(tert-butyldiphenylsilyloxy)hexyl-4-nitrophenyl carbonate

[0233] 3.(R)-6-(tert-butyldiphenylsilyloxy)hexyl-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropylcarbamate

[0234] 4.(R)-1,1-bis(4-methoxyphenyl)-17,17-dimethyl-7-oxo-1,16,16-triphenyl-2,8,15-trioxa-6-aza-16-silazoctadecane-4-yl 2,2-dichloroacetate

[0235] 5. (R)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-((6-hydroxyhexyloxy)carbonylamino)propyl-2-yl 2,2-dichloroacetic acid ester

[0236] Example 5: Universal connector phosphorous amide (TBDMS protected) – ULP3

[0237] ULP3 was prepared using fluoride-triggered silyl protecting groups instead of base-triggered DCA protecting groups. Figure 7 The synthesis begins with (R)aminopropanediol, such as... Figure 4The results show that, however, TBDMS-Cl was used to protect the secondary hydroxyl group (yield of 66% in 3 steps). The protecting group of trifluoroacetamide was removed with ammonium hydroxide. The reaction of the amine with 6-aminohexanol activated by p-nitrophenyl chloroformate (4-NPC) produces a urea bond. In this example, the primary alcohol was directly phosphorylated to give the desired phosphorylated amide (ULP 3). An intermediate compound generated during the preparation of ULP 3 (…) Figure 7 As described below:

[0238] 1. (R)-N-(3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-hydroxypropyl)-2,2,2-trifluoroacetamide (MW 489.48)

[0239] 2. (R)-N-(3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-(tert-butyldimethylsilyloxy)propyl)-2,2,2-trifluoroacetamide (MW 603.74)

[0240] TLC(ethyl acetate–hexane [1:5])R f =0.59; Mass spectrometry (EI mode) m / z 604 [M+H] + .

[0241] 3. (R)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-(tert-butyldimethylsilyloxy)prop-1-amine (MW 507.74)

[0242] TLC (methanol-ethyl acetate [1:5])R f =0.60; 1 ¹H NMR (dimethyl-d6 sulfoxide) δ 7.63 (br s), 7.31 (5H, m), 7.21 (4H, d, J = 9.3 Hz), 6.87 (4H, d, J = 9.3 Hz), 3.94 (1H, m), 3.71 (6H, s), 3.08–2.81 (4H, 2x m), 0.77 (9H, s), 0.00 (3H, s), -0.10 (3H, s); Mass spectrometry (EI mode) m / z 508 [M+H] + .

[0243] 4. (R)-1-(3-(bis(4-methoxyphenyl)(phenyl)methoxy)-2-(tert-butyldimethylsilyloxy)propyl)-3-(6-hydroxyhexyl)urea (MW 650.92)

[0244] TLC (ethyl acetate)R f =0.54; 1¹H NMR (dimethyl-d6 sulfoxide) δ 7.38–7.16 (9H, m & d, J = 9.0 Hz for doublet), 6.84 (4H, d, J = 9.0 Hz), 5.88 (1H, t, J = 6.0 Hz), 5.52 (1H, t, J = 6.0 Hz), 4.29 (1H, t, J = 3.0 Hz), 3.79 (1H, m), 3.70 (6H, s), 3.34 (2H, m), 3.08 (2H, m), 2.90 (4H, m), 1.27 (8H, m), 0.80 (9H, s), 0.00 (3H, s), -0.05 (3H, s); Mass spectrometry (EI mode) m / z 651 [M+H] + .

[0245] 5. (R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-2,2,3,3-tetramethyl-8-oxo-4-oxa-7,9-diaza-3-silazopentane-15-yl-cyanoethyldiisopropylphosphonamide (ULP3) (MW 851.14)

[0246] 1 ¹H NMR (dimethyl-d6 sulfoxide) δ 7.37 (2H, d, J = 6.0 Hz), 7.22 (7H, d & m, J = 9.0 Hz for doublet), 6.84 (4H, d, J = 9.0 Hz), 5.88 (1H, t, J = 6.0 Hz), 5.22 (1H, t, J = 6.0 Hz), 3.79 (1H, m), 3.74–3.64 (8H, m & s), 3.54 (4H, m), 3.07 (2H, m), 2.89 (4H, m), 2.72 (2H, t, J = 6.0 Hz), 1.49 (2H, m), 1.26 (6H, m), 1.11 (12H, m), 0.80 (9H, s), 0.00 (3H, s), -0.05 (3H, s); 31 P NMR (acetonitrile-d3) δ 146.98; Mass spectrometry (EI mode) m / z 851 [M+H] + .

[0247] Example 6: Preparation of DMT-CPG

[0248] The performance of general-purpose connector phosphorous amide was evaluated using a controlled-pore glass (CPG) solid support. Firstly, as... Figure 8The preparation of a model support (DMT-CPG) is shown. A commercially available long-chain alkylamine CPG (LCAA-CPG) was modified to provide a solid surface with a known loading of dimethoxytriphenylmethyl groups per gram of CPG. A novel reagent was first prepared by reacting p-nitrophenyl chloroformate with 6-aminohexanol. After the specific reaction of the amine with the chloroformate (as demonstrated by TLC), DMT-chloride was added in the same vessel to react with the primary alcohol. The resulting DMT-protected PNP carbamate was obtained as a pure product after silica gel chromatography. Further reaction with LCAA-CPG (147 μmol / g) yielded DMT-CPG (99 μmol / g), which was used for further determination of ULP, such as… Figure 9 It is displayed in the middle.

[0249] Example 7: Evaluation of DMT-CPG assays involving immobilization, coupling, and cleavage of ULP reagents

[0250] For ULP1 and ULP3, the behavior of general-purpose connector phosphorusamide under different cutting conditions was evaluated using DMT-CPG, such as... Figure 9 As shown in the diagram. For example, weigh out 3 μmol (30 mg) of CPG (DMT loading = 99 μmol / g) and place it in a flow-through DNA synthesis column (Biosearch Technologies, part number CL-1501-10) with disposable glass flakes. Remove the DMT groups with 5% TCA / DCM (5 min at RT). Use a 76 mL cm⁻¹ column. -1 μmol -1The extinction coefficient was determined, and the concentration of the triphenylmethyl cation was recorded from the visible spectral peak at the maximum absorbance (approximately 498 nm). CPG was washed with acetonitrile and then coupled with 1 mL of a 1:1 mixture of 0.1 M ULP and 0.1 M DCI (4,5-dicyanimidazole) in acetonitrile. After 5 min, ULP was washed off the CPG with acetonitrile and then oxidized with iodine in pyridine / water (5 min). CPG was treated with 5% TCA / DCM, and the concentration of the triphenylmethyl cation was measured, and the coupling percentage of ULP to CPG was calculated. UL-CPG was washed with acetonitrile and then coupled with 1 mL of a 1:1 mixture of 0.1 M BHQ-1 (Black Hole Quencher 1) DMT phosphorous acid (Biosearch Technologies, part number BNS-5051-50) and 0.1 M DCI (4,5-dicyanimidazole). After 5 min, the BHQ-1 imine was washed off the CPG with acetonitrile, followed by oxidation with iodine in pyridine / water (5 min). UL-BHQ-1 CPG was treated with 5% TCA / DCM, the concentration of triphenylmethyl cations was measured, and the coupling percentage of BHQ-1 to UL-CPG was calculated. UL-BHQ-CPG was dried under vacuum (approximately 30 mg) and used to study the release of BHQ-1 into solution. A 34 mL cm⁻¹ solution was used. -1 μmol -1 The extinction coefficient was used to record the concentration of BHQ-1 from the visible spectral peak at the maximum absorbance (approximately 534 nm). As described in Example 1, 2–3 mg of UL1-BHQ-CPG or UL2-BHQ-CPG was treated with 4M ammonia in anhydrous methanol, and the BHQ-1 release percentage was measured over time. Similarly, UL3-BHQ-CPG was treated with 1.6% (v / v) TEA:3HF in anhydrous methanol, and the BHQ-1 release percentage was measured over time. Figure 12 The kinetics of cleavage of BHQ1 from CPG-UL3-BHQ1 in 1.6% (v / v) TEA:3HF / MeOH at 22 °C (+ / - 0.2 °C), as determined by spectrophotometry, are shown.

[0251] Example 8: Simultaneous synthesis of DNA primer pairs using universal phosphorusamide

[0252] A common application of automated DNA synthesis is for generating PCR primers. PCR uses a pair of custom primers to guide DNA to extend towards each other at opposite ends of the sequence being amplified. These primers are typically 18 to 24 bases long and must encode only specific upstream and downstream sites of the sequence being amplified, such as... Figure 10 It is displayed in the middle.

[0253] High concentrations of PCR primers are required, thus preventing their synthesis on array instruments. However, standard DNA synthesis of primers would benefit from a novel method using a universal adapter phosphoramide to prepare two primers in a single synthesis column. Figure 11 The procedure involves introducing UL phosphoramidite as a spacer between the DNA sequences of primer 1 and primer 2. After detriphenylmethylation of the DNA, the solid support is treated with 4M methylamine / MeOH. The primer 1 sequence is released from the solid support using a commonly used 3'-hydroxyl group. Simultaneously, the universal adapter spacer is cleaved to obtain the primer 2 sequence with a 3'-hydroxyl group. The protecting groups are removed with AMA to produce a 1:1 mixture of primers 1 and 2. Evaporation of the AMA leaves a 1:1 mixture of primers, along with contaminated ineffective sequences and the removed protecting groups. Acetyl-protected dC (Ac-dC) is required instead of benzoyl-protected dC to prevent transamidation by aqueous methylamine. The oligomers are deprotected using concentrated ammonia (55°C, 1 hour) or AMA (55°C, 10 minutes).

[0254] Typically, PCR primers are purified by removing the 5'-triphenylmethyl group from the oligomers and simply "desalting" them using a gel filtration column. Gel filtration separates the components of a mixture based on molecular size and is the simplest form of chromatography for oligonucleotide purification. Cleavage protecting groups and truncated sequences remain in the gel matrix, while larger oligonucleotide molecules elute rapidly through the gel filtration column. Since primer 1 and primer 2 are approximately the same length, they elute with the same fraction. The concentration of the 1:1 primer mixture is determined by the absorbance at 260 nm using the combined extinction coefficient of the two oligomers. End users can directly use the 1:1 mixture in PCR without having to determine the concentration of each primer individually and calculate the volume of each primer.

[0255] All publications and patent applications mentioned in this specification indicate the skill level of a person skilled in the art to which this invention pertains. All publications and patent applications are incorporated herein by reference to the extent that each individual publication or patent application is specifically and individually indicated to be incorporated by reference.

[0256] Although the invention has been described in detail by way of illustration and example for purposes of clarity, it will be apparent that certain changes and modifications may be made within the scope of the appended claims.

Claims

1. A solid support system for synthesizing oligonucleotides, wherein the support comprises a planar surface and a universal linker, wherein the universal linker is coupled to the planar surface, wherein the planar surface comprises silicon, titanium, or platinum, and wherein the universal linker is represented by formula (VII), (IX), or (X). Equation (VII): ; Formula (IX): ; Equation (X): 。 2. The solid support system of claim 1, wherein the planar surface is coated with amine prior to attaching the universal connector.

3. The solid support system of claim 1, wherein the planar surface is coated with a carboxylic acid.

4. The solid support system of claim 2, wherein the planar surface is coated with a carboxylic acid.

5. The solid support system according to any one of claims 1-4, wherein the planar surface is coated with monosaccharides or disaccharides.

6. The solid support system of claim 5, wherein the monosaccharide is selected from the group consisting of: allose, arabinose, arabinose, deoxyribose, erythrose, fructose, galactose, glucose, gulose, idose, lysose, mannose, allulose, L-rhamnose, ribose, ribulose, sedoheptulose, D-sorbitol, sorbose, xylulose, tagatose, taloose, threose, xylulose, and xylose, and the disaccharide is selected from the group consisting of: sucrose, amylose, cellobiose, lactose, maltose, melibiose, isomaltulose, and trehalose.

7. A method for synthesizing oligonucleotides, the method comprising: (a) Provide an electrode device having a planar surface; (b) Couple the surface to a universal connector; as well as (c) Synthesize the oligonucleotide, The universal connector mentioned above is represented by formula (VII), (IX) or (X). Equation (VII): ; Formula (IX): ; Equation (X): 。 8. The method of claim 7, wherein the method further comprises the following steps: The carboxylic acid is electrochemically reduced and deposited onto the planar surface.

9. The method of claim 7 or 8, wherein the method further comprises depositing an amine coating onto an activated carboxylic acid.

10. The method of claim 7, wherein the planar surface comprises silicon, titanium, or platinum.

11. The method of claim 7, wherein the planar surface is coated with a monosaccharide or a disaccharide.

12. A method for synthesizing oligonucleotide primer pairs, the method comprising: A solid support is provided, comprising a first universal connector, the first universal connector being fixed to the surface of the solid support; The first universal connector is represented by formula (VII), (IX) or (X). A first phosphoramide DNA synthesis is performed to generate a first oligonucleotide primer, wherein the 3' end of the first oligonucleotide primer is attached to the first universal adapter. The second universal adapter is coupled to the 5' end of the first oligonucleotide primer; A second phosphoramide DNA synthesis is performed to generate a second oligonucleotide primer, wherein the 3' end of the second oligonucleotide primer is attached to the second universal adapter. The second universal connector is represented by formula (VII), (IX) or (X); as well as The solid support is contacted with a releasing agent to release the first oligonucleotide primer and the second oligonucleotide primer from the solid support, wherein each of the released first oligonucleotide primer and the released second oligonucleotide primer contains a 3'-hydroxy group.

13. The method of claim 12, wherein the releasing agent comprises 4 M methylamine / MeOH or TEA:3HF.

14. The method of claim 12, further comprising removing the protecting groups from the released first oligonucleotide primer and the released second oligonucleotide primer with AMA (1:1, 37% ammonium hydroxide: 40% methylamine).

15. The method of claim 13, further comprising removing the protecting groups from the released first oligonucleotide primer and the released second oligonucleotide primer with AMA (1:1, 37% ammonium hydroxide: 40% methylamine).

16. The method of claim 14, wherein the released first oligonucleotide primer and the released second oligonucleotide primer are substantially the same length.

17. The method of claim 15, wherein the released first oligonucleotide primer and the released second oligonucleotide primer are substantially the same length.

18. The method of claim 16, wherein the concentration ratio of the released first oligonucleotide primer to the released second oligonucleotide primer is about 1:

1.

19. The method of claim 17, wherein the concentration ratio of the released first oligonucleotide primer to the released second oligonucleotide primer is about 1:

1.

20. The method of any one of claims 12-19, wherein the method is performed in a single column.

21. The solid support system of any one of claims 1-2 and the method of claim 7, wherein the universal connector is represented by formula (X).

22. The method of any one of claims 12-19, wherein the first universal connector and / or the second universal connector is represented by formula (X).

Citation Information

Patent Citations

  • Neutralization and containment of redox species produced by circumferential electrodes

    US10525436B2

  • Phosphoramidite compounds and processes

    US4415732A

  • Process for preparing polynucleotides

    US4458066A

  • Nucleosides useful in the preparation of polynucleotides

    US4500707A

  • Phosphoramidite nucleoside compounds

    US4668777A